BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12411762)

  • 1. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease.
    Kantarci K; Xu Y; Shiung MM; O'Brien PC; Cha RH; Smith GE; Ivnik RJ; Boeve BF; Edland SD; Kokmen E; Tangalos EG; Petersen RC; Jack CR
    Dement Geriatr Cogn Disord; 2002; 14(4):198-207. PubMed ID: 12411762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
    Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ
    Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.
    Kantarci K; Smith GE; Ivnik RJ; Petersen RC; Boeve BF; Knopman DS; Tangalos EG; Jack CR
    J Int Neuropsychol Soc; 2002 Nov; 8(7):934-42. PubMed ID: 12405545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
    Kantarci K; Jack CR; Xu YC; Campeau NG; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG; Petersen RC
    Neurology; 2000 Jul; 55(2):210-7. PubMed ID: 10908893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of functional MRI markers in mild cognitive impairment.
    Zhang B; Li M; Sun ZZ; Zhu B; Yuan L; Wang Y; Xu Y
    J Clin Neurosci; 2009 May; 16(5):635-41. PubMed ID: 19264490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
    Kantarci K; Reynolds G; Petersen RC; Boeve BF; Knopman DS; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
    AJNR Am J Neuroradiol; 2003 May; 24(5):843-9. PubMed ID: 12748083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality Neuroimaging in Mild Cognitive Impairment: A Cross-sectional Comparison Study.
    Sheelakumari R; Sarma SP; Kesavadas C; Thomas B; Sasi D; Sarath LV; Justus S; Mathew M; Menon RN
    Ann Indian Acad Neurol; 2018; 21(2):133-139. PubMed ID: 30122839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
    Zimny A; Szewczyk P; Trypka E; Wojtynska R; Noga L; Leszek J; Sasiadek M
    J Alzheimers Dis; 2011; 27(3):591-601. PubMed ID: 21841260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
    Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR
    Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.